Earnings Labs
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC)

NASDAQ·Healthcare·Biotechnology

$6.73

-1.75%

Mkt Cap $209.10M

Analyst Ratings

No recent rating data.

Price Target (8 analysts)

$18.00

Range $18.00$18.00

Implied Upside

+167.5%

Consensus $18.00 vs current $6.73